Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes

AIMS: Gliclazide pharmacokinetics and pharmacodynamics were assessed in 9 Caucasians and 10 Australian Aborigines with uncomplicated type 2 diabetes. METHODS: Subjects were on a stable dose of 80 mg gliclazide twice daily, took 160 mg on the morning of study and had a standard breakfast. No further...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Davis, Timothy M E, Daly, Frank, Walsh, John P, Ilett, Kenneth F, Beilby, John P, Dusci, Leon J, Barrett, P Hugh R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 2000
Gaiak:
Pharmacokinetics/Pharmacodynamics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2014921/
https://ncbi.nlm.nih.gov/pubmed/10718777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2000.00162.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak